title: Quantifying rates of protein synthesis in humans by use of 2H2O: application to patients with end-stage renal disease.
abstract: A method is introduced for quantitating protein synthetic rates in humans by use of (2)H(2)O. Its validity was tested in subjects with end-stage renal disease. Six clinically stable subjects, hemodialyzed three times weekly, ingested (2)H(2)O to a body water (2)H enrichment of approximately 0.4%. On dialysis, body water enrichment declined to approximately 0.1%. Enrichment of the alpha-hydrogen of plasma free alanine was also approximately 0.4% before and approximately 0.1% after dialysis. Beta-hydrogen enrichment was approximately 80-100% of alpha-hydrogen enrichment. (2)H(2)O was ingested to replace (2)H(2)O removed after each dialysis for 15-51 days, returning enrichment to approximately 0.4%. Enrichment of alanine from plasma albumin gradually increased, with again approximately 80-100% as much (2)H in beta- as in alpha-hydrogens. With continued dialyses, without (2)H(2)O replacement, alanine from albumin enrichment gradually declined, whereas free alanine and water enrichments were negligible. The fractional albumin synthesis rate, calculated from the increase in enrichment in alanine from albumin, was 4.0 +/- 0.5%/day, and from the decrease, 4.6 +/- 0.2%/day. Thus body water enrichment in a subject given (2)H(2)O can be maintained constant long term. A rapid exchange, essentially complete, occurs between the hydrogens of alanine and body water. An integrated measure over a long period of albumin's synthetic rate can be estimated from both the rise in enrichment of alanine from the protein during (2)H(2)O ingestion and fall on (2)H(2)O withdrawal, while the subject's living routine is uninterrupted. Estimates are in subjects with renal disease, but the method should be applicable to estimates of protein synthetic rates in normal subjects and in other pathological states.
authors.affiliation: Department of Medicine, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106-4951, USA.
authors.forename: Stephen F
authors.initials: SF
authors.lastname: Previs
authors.forename: Richard
authors.initials: R
authors.lastname: Fatica
authors.forename: Visvanathan
authors.initials: V
authors.lastname: Chandramouli
authors.forename: James C
authors.initials: JC
authors.lastname: Alexander
authors.forename: Henri
authors.initials: H
authors.lastname: Brunengraber
authors.forename: Bernard R
authors.initials: BR
authors.lastname: Landau
mesh_terms: D000328:Adult; D000368:Aged; D000409:Alanine / Q000097:blood / Q000378:metabolism; D001834:Body Water / Q000378:metabolism; D017666:Deuterium Oxide; D005260:Female; D006801:Humans; D006859:Hydrogen / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D014176:Protein Biosynthesis; D006435:Renal Dialysis; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D012709:Serum Albumin; D006859:Hydrogen; D017666:Deuterium Oxide; D000409:Alanine